Pfizer is working on an annual coronavirus vaccine that could replace frequent booster doses.
According to the news agency Reuters, the information was confirmed by the pharmaceutical company’s CEO, Albert Bourla.
Pfizer/BioNtech’s vaccine has been shown to be effective against serious illness and death caused by the infectious omicron variant. On the other hand, it is less effective in preventing infection.
In an interview with the Israeli channel N12 News, Bourla was asked if he envisions the necessity for booster doses every four to five months in the future.
“That would not be a good scenario. I hope we will have a vaccine that you can take once a year. Once a year – it’s easier to convince people to do it. It’s easier for people to remember,” he said.
Israel now offers a fourth vaccine dose to anyone over the age of 60, as well as employees in the health sector. Still, a fourth vaccine dose provides little increased protection against the omicron variant, an Israeli study showed.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at firstname.lastname@example.org